Inflammatory bowel disease in children.
Ulcerative colitis and Crohn's disease are chronic intestinal disorders with diverse presentations that must be familiar to pediatricians. The subtlety of clinical signs and symptoms may be overshadowed by extraintestinal complications. An awareness of diagnostic techniques and the necessity of an integrated approach of medical and surgical management is emphasized. Potential complications may affect prognosis and require their own specific therapy. The management of these disorders entails an individualized assessment of the extent and severity of intestinal involvement, extraintestinal complications, as well as ongoing medical, nutritional, and emotional support.
D001466:Barium Sulfate; D002648:Child; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004733:Enema; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010288:Parenteral Nutrition; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012460:Sulfasalazine / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D001466:Barium Sulfate; D012460:Sulfasalazine; D011241:Prednisone